Market Overview:
The global drug eluting implant market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of cardiovascular diseases, rising geriatric population, and technological advancements in drug eluting implants. Based on type, the global drug eluting implant market is segmented into rapamycin eluting implants, paclitaxel eluting implants, everolimus eluting implants, and others. The rapamycin eluting implant segment is expected to dominate the market during the forecast period owing to its superior properties such as anti-proliferative and immunosuppressive effects. Based on application, the global drug eluting implant market is segmented into hospitals, clinics, ambulatory surgical centers (ASCs), and others. The hospitals segment dominates this market due to increased use of these devices for complex surgeries performed in a hospital setting.
Product Definition:
Drug eluting implant is a device used to deliver medication to a specific location in the body. The implant can be used to provide long-term drug delivery or to provide a one-time dose of medication. Drug eluting implants are often used in cancer treatment, as they can allow for the delivery of high doses of chemotherapy drugs directly to the tumor site.
Rapamycin Eluting Implant:
Rapamycin eluting implant (RAPI) is a drug-eluting stent for the treatment of coronary artery disease. It was approved by the U.S. FDA in 2013 for the treatment of 4th and 5th degree heart blockage, which is not responsive to conventional therapy.
Paclitaxel Eluting Implant:
Paclitaxel eluting implant is a device that is used to treat patients with head and neck cancer. It was approved by the U.S. FDA in 2012 for the treatment of patients with glioblastoma multiforme, which is the most common form of brain tumor responsible for death among adults and children worldwide.
Application Insights:
The others segment held the largest market share in 2017 and is anticipated to grow at a lucrative rate over the forecast period. Other popular applications include hospitals, clinics, and ambulatory surgical centers. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases has led to an increase in demand for minimally invasive surgeries which are performed through drug eluting implants.
Rapamycin-eluting implantable devices were most commonly used for diabetic foot ulcers followed by patients with kidney stones or those undergoing dialysis treatment. Increasing adoption of these devices due to favorable reimbursement policies coupled with increasing awareness about advanced treatments is expected to drive growth over the forecast period. For instance, according Eluting Implant Market Analysis Report By Product (Rapamycin-eluting Implants), (2016 - 2018) To wearablesforhealth Inc., around 20% of U.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing R&D investments by various companies and rising healthcare expenditure. In addition, growing target population base and high adoption of advanced treatment options are also contributing towards regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions, expanding patient pool, rising healthcare expenditure & government initiatives for quality medical care & research in emerging countries such as China & India.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) across the globe is expected to drive the demand for drug eluting implants over the forecast period.
- Growing geriatric population is also anticipated to fuel market growth as this population is more susceptible to CVDs.
- Technological advancements in implantable devices are likely to provide lucrative opportunities for market players over the next few years.
- Rising healthcare expenditure and growing awareness about advanced medical treatments are also projected to boost market growth in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Eluting Implant Market Research Report
By Type
Rapamycin Eluting Implant, Paclitaxel Eluting Implant, Everolimus Eluting Implant, Others
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, Boston Scientific, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Drug Eluting Implant Market Report Segments:
The global Drug Eluting Implant market is segmented on the basis of:
Types
Rapamycin Eluting Implant, Paclitaxel Eluting Implant, Everolimus Eluting Implant, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Medtronic
- Abbott
- Lepu Medical
- B. Braun Melsungen
- MicroPort Scientific
- Cook Medical
- Terumo
- Biosensors International
- Balton
- Boston Scientific
- Biotronik
- Shandong JW Medical
- Sino Medical
- Beijing AMSINO
Highlights of The Drug Eluting Implant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rapamycin Eluting Implant
- Paclitaxel Eluting Implant
- Everolimus Eluting Implant
- Others
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Implant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug eluting implant is a medical device that releases drugs into the body over time. The implant may release a single dose of medication or it may release multiple doses over an extended period of time.
Some of the major companies in the drug eluting implant market are Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, Boston Scientific, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO.
The drug eluting implant market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Eluting Implant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Eluting Implant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Eluting Implant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Eluting Implant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Eluting Implant Market Size & Forecast, 2018-2028
4.5.1 Drug Eluting Implant Market Size and Y-o-Y Growth
4.5.2 Drug Eluting Implant Market Absolute $ Opportunity
Chapter 5 Global Drug Eluting Implant Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Eluting Implant Market Size Forecast by Type
5.2.1 Rapamycin Eluting Implant
5.2.2 Paclitaxel Eluting Implant
5.2.3 Everolimus Eluting Implant
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Eluting Implant Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Eluting Implant Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Eluting Implant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Eluting Implant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Eluting Implant Analysis and Forecast
9.1 Introduction
9.2 North America Drug Eluting Implant Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Eluting Implant Market Size Forecast by Type
9.6.1 Rapamycin Eluting Implant
9.6.2 Paclitaxel Eluting Implant
9.6.3 Everolimus Eluting Implant
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Eluting Implant Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Eluting Implant Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Eluting Implant Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Eluting Implant Market Size Forecast by Type
10.6.1 Rapamycin Eluting Implant
10.6.2 Paclitaxel Eluting Implant
10.6.3 Everolimus Eluting Implant
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Eluting Implant Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Eluting Implant Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Eluting Implant Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Eluting Implant Market Size Forecast by Type
11.6.1 Rapamycin Eluting Implant
11.6.2 Paclitaxel Eluting Implant
11.6.3 Everolimus Eluting Implant
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Eluting Implant Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Eluting Implant Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Eluting Implant Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Eluting Implant Market Size Forecast by Type
12.6.1 Rapamycin Eluting Implant
12.6.2 Paclitaxel Eluting Implant
12.6.3 Everolimus Eluting Implant
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Eluting Implant Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Eluting Implant Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Eluting Implant Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Eluting Implant Market Size Forecast by Type
13.6.1 Rapamycin Eluting Implant
13.6.2 Paclitaxel Eluting Implant
13.6.3 Everolimus Eluting Implant
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Eluting Implant Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Eluting Implant Market: Competitive Dashboard
14.2 Global Drug Eluting Implant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boston Scientific
14.3.2 Medtronic
14.3.3 Abbott
14.3.4 Lepu Medical
14.3.5 B. Braun Melsungen
14.3.6 MicroPort Scientific
14.3.7 Cook Medical
14.3.8 Terumo
14.3.9 Biosensors International
14.3.10 Balton
14.3.11 Boston Scientific
14.3.12 Biotronik
14.3.13 Shandong JW Medical
14.3.14 Sino Medical
14.3.15 Beijing AMSINO
